Sarepta Therapeutics (SRPT) Update
Q2 Earnings with Key Metrics
SRPT Q2 2025 — detailed earnings summary
Headline results
Total revenue: $611.1M (+68% YoY). Net product revenue: $513.1M (+42% YoY). Company reported GAAP operating income $115.6M and non-GAAP operating income $162.8M. GAAP net income $196.9M (GAAP EPS $1.89); non-GAAP EPS $2.02.
Cash & investments: Ended the quarter with $850.3M, and said the quarter wa…
